Patient P-02519

Synthetic patientMETA-24 · Day 169 · 35–44 · M · baseline S20Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

16%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S20

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity-3
Treatment adherence-3
Nutritional resilience-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

29 min

worsening · -3.4 vs previous 14 d

Sleep duration

Wearable

6.4 h

worsening · -0.3 vs previous 14 d

Energy level

Daily log

6.8/10

stable · -0.2 vs previous 14 d

Steps

Wearable

4,016

worsening · -389 vs previous 14 d

GI burden

Companion

25/100

worsening · +11.5 vs previous 14 d

Adherence

Companion

94.3 %

stable · +2.0 vs previous 14 d

Sleep quality

Wearable

37.5/100

worsening · -5.7 vs previous 14 d

Glucose, CGM daily mean

CGM

129 mg/dL

worsening · +5.6 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 88 from the failing basin, 15 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +5.3
Protein
supporter · GI -2.9 next day

Main detractors to watch

Bacteroides fragilis elevated
hidden · steering -7.4
Antibiotic course
perturbation · steering -4.7
Alcohol
perturbation · steering -3.5
Ultra-processed food
perturbation · steering -3.4
Alcohol
detractor · GI +2.1 next day
Ultra-processed food
detractor · GI +2.1 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-2.9supporter · 95%
Alcohol
+2.1detractor · 67%
Ultra-processed food
+2.1detractor · 58%
Histamine load
+1.9detractor · 56%
Caffeine
-1.3no signal · 46%
Simple carbohydrates
+0.9no signal · 26%
Insoluble fibre
-0.3no signal · 15%
Dietary fat load
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓45
- WearableResting HR 74 bpm
- WearableShort sleep window
Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 28 ms, trending down
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 3.5 · butyrate capacity 74/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 30 ms
Sleep: 6.1 h
Steps: 4,924
Resting HR: 73 bpm

Daily log: GI score 25, nutritional resilience 61, adherence 94.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02415	48%	S17	GI-04	improved	86
P-02667	45%	S08	HY-01	improved	77
P-02450	41%	S12	NP-02	improved	92
P-02630	39%	S17	NP-02	improved	76
P-02486	38%	S10	ME-01	improved	86
P-02193	37%	S11	CR-01	improved	87
P-02277	37%	S05	AD-05	improved	92
P-02690	36%	S02	ME-01	improved	73
P-02249	34%	S09	DT-01	improved	100
P-02354	33%	S01	CR-01	improved	78
P-02068	31%	S14	NP-02	improved	83
P-02464	31%	S18	ME-01	improved	68